New York, NY 10065
United States
Memorial Sloan Kettering Cancer Center
Mutational signatures, CRISPR screen, homologous recombination repair, synthetic lethality, isogenic cell lines, PARP inhibitor resistance, therapeutic vulnerability, BRCA, DNA repair, mutagenesis